Although we failed to detect any clinical impact of TAZ expression deregulation on the TCGA-esophageal cancer cohort, likely due to its lower expression than YAP1, TAZ silencing indeed reduced esophageal cancer cell proliferation, migration and invasion. The gene discussed is YAP1; the disease is esophageal cancer.